AIDS: overview and VA update. by Cohn, H. D.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 60 (1987), 515-525
AIDS: Overview and VA Update*
H.D. COHN, M.D.
Deputy Assistant ChiefMedical Directorfor Clinical Affairs, Department of
Medicine and Surgery, VA Central Office, Washington, D.C.
Received January 28, 1987
Acquired immune deficiency syndrome (AIDS), a devastating disease with numerous masks
(e.g., a primary neurosymptomatic disease), has now been reported in over one hundred countries
oftheworld. Projections by the Public Health Service ofthe numbersofcases andfatal illnesses in
the United States by 1991 stagger the imagination, and we are told that these projections may be
understated. The Veterans Administration (VA) has not been immune tothis disorder, over 2,000
cases of frank AIDS (as defined by the Centers for Disease Control [CDC] having been reported
to VA's Central Office by 111 of the VA's 172 medical centers. These figures do not include
AIDS-related complex (ARC) or other manifestations of human immunodeficiency virus (HIV)
infection. Seventy-seven percent of this total have been reported from 22 of the VA's largest
tertiary care centers.
The VA has developed an action plan, one of whose features is the development of a direct
discussion and collaboration with other federal health care agencies, including the military.
Emphasis is to be placed on the exchange ofinformation among these various executive branches
and, most important, on the smooth transfer of patients with AIDS or ARC from the uniformed
services into the VA's health care system.
In addition to the primary goal of providing timely, compassionate care to these patients, the
VA also has a commitment to thedissemination ofinformation to our patients, their families, and
our employees.
Acquired immune deficiency syndrome (AIDS) is a national emergency requiring
attention from all citizens. This statement has no less meaning for the Veterans
Administration (VA) health care system than it does for the nation at large. The VA is
heavily involved in the care and management of a large group ofveterans with AIDS
and AIDS-related illnesses.
Few peopleoutside the federal system realize the VA has treated over 2,000 patients
with frank AIDS. That number is considerably higher, for example, than the combined
number ofcases from all branches ofthe military; it represents about 6 percent of all
cases reported to the Centers for Disease Control (CDC). Moreover, the true number
of cases treated is certainly higher due to underreporting, a factor common to all
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TABLE 1
Historical Evolution of AIDS
Year Interval Cases Deaths
1979 First half 1 1
Second half 8 6
1980 First half 19 14
Second half 26 26
1981 First half MMWR' reports AIDS in male homosexuals 77 66
Second half AIDS found in IV drug abusers 162 131
1982 First half Chronic lymphadenopathy: AIDS prodrome? 334 236
Second half AIDS found in Haitians, hemophiliacs 621 385
1983 First half AIDS found in prisoners, females 1,099 537
Second half AIDS found in children 1,375 546
1984 First half HTLV-III first described 1,404 363
Second half' Serologic test available for HTLV-III N/A N/A
Total 5,126 2,311
Data obtained from the CDC AIDS Weekly Surveillance Report, July 9, 1984
aMMWR, Morbidity andMortality Weekly Report (a publication ofthe CDC)
bData now available from CDC
reporting systems, and the fact that there are always additional case reports in the
reporting pipeline.
This paper is presented in two parts, the first dealing with a brief history of AIDS
and the second with an update ofthe problem in the Veterans Administration.
BRIEF HISTORY OF AIDS
General Overview
The disease, AIDS, now known to be caused by a virus (human immunodeficiency
virus, HIV), has probably existed in this country for at least seven years. The term
"AIDS" is appropriately used to refer to a spectrum of illnesses caused by the HIV.
The protean clinical manifestations ofAIDS bring to mind the Oslerian aphorism: "To
know syphilis is to know medicine." That statement is gaining further meaning in
relation to AIDS.
The disease may have originated in central Africa, migrated to western Europe, and
the Caribbean, and thence into the United States. Some see America as having
exported thedisease to other partsofthe world in recent years. In any case, the disease
is now worldwide in its distribution, having been reported in over 100 countries [1].
The disease's historical evolution through 1984 is portrayed in Table 1.
Far more impressive is the 1986 data and projected data beyond 1986 (Reportofthe
Coolfont Planning Conference, June 4-6, 1986) [2]. At the end of 1991, for example,
theprojectedcumulative number ofcases is 270,000, with thecumulative deaths at the
end of that year estimated to be 179,000. These numbers reflect only those cases that
meet the current CDC definition for AIDS and do not include the increasing array of
clinical manifestations being reported in the literature that may not meet the
moderately restrictive CDC surveillance definition. These clinical manifestations are
grouped under the diagnosis ofAIDS-related complex (ARC).
Those individuals presumed to be infected number from one to two million. An
alarming note is the frequency with which those who possess antibodies to AIDS are
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FIG. 1. Incidence ofAIDS in the United States.
progressing to ARC and/or AIDS. Originally estimated to be between 5 and 10
percent, the percentage of those who progress to full-blown AIDS approximates 30
percent. Conservatively, another 20-40 percent will probably progress to other
symptomatic manifestations of HIV infection.
Epidemiology
The epidemiology has been well worked out by officials at the CDC and others
[1,2,3,4]. At present (Spring 1987) over 36,000 cases have been reported to CDC (Fig.
1), with a cumulative mortality rate of 56 percent. The case fatality rate for frank
AIDS approximates 100 percent.'
Risk-group patterns have received much attention. Table 2 lists the population
groups at greatest risk. Clearly, members of the first two risk groups, namely
homosexual/bisexual males and intravenous (IV) drug abusers, are at greatest risk
and have rather consistently represented about 89-90 percent of the total. The
relationship among the various groups has remained relatively constant since the
inception of the epidemic. That two of the nation's major health problems (i.e., drug
abuse and AIDS) are interwoven is now evident.
At present 7 percent of the total cases are in heterosexual men and woman. The
percentage of the total cases among heterosexual men and women is predicted to
increase modestly to 9 percent by 1991. We do know that AIDS can be transmitted
bi-directionally, although male-to-female spread appears tobefar morelikely than the
converse.
Table 2, however, portrays what is happening only in an adynamic manner. When
oneconsiders that the majority ofthe hemophiliacs in this country areAIDS-antibody
positive (enzyme-linked immunosorbent assay [ELISA] and Western blot confirmato-
ry) byvirtue ofhaving received contaminated anti-hemophilic concentrate therapeuti-
'Information/Education Plan to Prevent and Control AIDS in the United States (January 1, 1987). U.S.
Department ofHealth and Human Services, Public Health Service. (CDC Publication)
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TABLE 2
Groups at Greatest Risk
1. Homosexual/bisexual males
2. IV drug abusers
3. Blood transfusion recipients
4. Hemophiliacs
5. Heterosexual partners ofabove risk groups (especially ofnumber 2)
6. Female prostitutes
7. Children ofparent(s) with AIDS or risk-group (RG) members
cally prior to the availability of the AIDS screening tests, some of the really tragic
proportions of the AIDS epidemic begin to unfold. Blood transfusion recipients
represent about 2 percent ofthe total number ofcases. This group has the potential to
diminish to zero in terms ofnew cases because ofmandatory testing ofall donor blood
and plasma. "Project look-back" (a program implemented by the nation's blood
collection agencies) has as its goal identification and communication of all contami-
nated donor blood identifier numbers to medical centers to which that blood was
distributed for possible transfusion. Patients who received contaminated transfusions
are to be contacted and counselled. Because of the timing of the availability of the
AIDS-antibody test (Spring 1985), additional cases may be reported, since the latency
period for developing AIDS may be as long as five years or more.
Figure 2 demonstrates the overlap between the two leading risk groups. Examining
thedata in another way, one concludes that the IV drug user group represents a higher
percentage than that shown in Tables 3 and 4, since IV drug users are included among
the homosexual/bisexual group where both risks are present in the same individual.
Approximately 25 percent ofall AIDS cases appear to involve intravenous drug use. In
the New York City area, cases belonging to the IV drug abuser group represent 34
percent ofthe total there.
As is now well known, it was the occurrence of Pneumocystis carinii pneumonia
(PCP) and other unusual infections in previously healthy male homosexuals that
United States, Aug. 22, 1985
N= 129579 814
Hemophilia/ 0 Coagulation
Homosexual/ 3 Disorder (85) None of the
omosexual/ 2 80 Other Groups
Bisexual (9220) / 0 Heterosexual Men(9220) ~ ~ ~ 'Contacts* (124)
8124 2153 __Recipients*
_ / I~~~~V Drug User
(3246)
*Excludes cases also reported as homo/bisexual,
IV drug abusers, or hemophiliacs
FIG 2. AIDS in adults by risk group.
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TABLE 3
AIDS Risk Group Patternsa
Percentage ofNew Cases
1981 1982 1985
Homosexual or bisexual men 77.7 71.6 73.8
Intravenous (IV) drug abusers 12.2 16.7 16.6
Persons with hemophilia 0.4 0.6 0.8
Heterosexual partners ofhigh-risk groups 0.4 1.0 1.2
Recipients ofblood 0.0 0.8 2.2
Others 9.3 9.3 5.5
'Includes Haitians, who were classified separately before 1984
presaged the AIDS epidemic [6]. The myriad of opportunistic infections that have
been associated with AIDS are listed in Table 5 [7]; the list is not all-inclusive.
Classification ofAIDS
Several different classification schemata for AIDS have been developed. The CDC
classification system [4] is shown in Table 6. It should prove useful in the design and
evaluation ofclinical investigation trials.
Ofspecial importance are theneuropsychiatric manifestations ofinfection with HIV
[5]. Approximately 30 percent of patients with AIDS have nervous system involve-
ment. This involvement may take many forms: a progressive dementing encephalitis, a
diffuse encephalopathy, focal brain abnormalities, or cranial and peripheral neuropa-
thies. The central nervous system (CNS) ofpatients with AIDS is also vulnerable to a
variety of opportunistic infections, including T. gondii and cryptococcosis. An
increased incidence ofCNS neoplasms, especially lymphomas, is also observed.
Thoroughgoing psychiatric and psychosocial management ofpatients with AIDS is
particularly important but may be alarmingly absent from the overall treatment plan.
AIDS PROGRAM IN THE VETERANS ADMINISTRATION
Initiation ofVA AIDS Program
The Veterans Administration admitted, in 1981, its first patient who subsequently
was found to have AIDS. In 1983, a formal reporting system was initiated for patients
TABLE 4
AIDS Risk Group Patterns in VA Patients
Percentage ofCases Reported
Between September 1983 and February 1987
Homosexual or bisexual males 44%
Intravenous (IV) drug abusers 26%
Homosexual males with IVDA' 7%
Persons with homophilia
Heterosexual exposure to high-risk persons 2.5%
Recipients ofblood or blood products 2.7%
Othersb 18%
aIVDA, intravenous drug abuse
bunreported or unknown are reported together.H.D. COHN
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with full-blown or frank AIDS. As of the spring of 1987, 2,000 cases have been
reported to VA Central Office (VACO) by 111 of the VA's 172 medical centers.
Seventy-seven percent of these 2,000 patients have been seen at 22 VA Medical
Centers (VAMCs), almost exclusively hospitals located in the coastal regions of the
United States plus San Juan, Puerto Rico. As with the national experience, the
cumulative mortality rate is in excess of50 percent. Eighty-two percentofthe patients
TABLE 6
Summary of Classification System for Human T-Cell Lymphotropic Virus, Type
III/Lymphadenopathy-Associated Virus Infection
Group I Acute infection
Group II Asymptomatic infection
Group III Persistent generalized lymphadenopathy
Group IV Other disease
Subgroup A Constitutional disease
Subgroup B Neurologic disease
Subgroup C Secondary infectious diseases
Category C-I Specified secondary infectious diseases listed
in the CDC surveillance definition for AIDS
Category C-2 Other specified secondary infectious diseases
Subgroup D Secondary cancers'
Subgroup E Other conditions
Patients in Groups II and III may be subclassified on the basis of a laboratory
evaluation.
'Includes those patients whose clinical presentation fulfills the definition of the
acquired immunodeficiency syndrome (AIDS) used by Centers for Disease Control
(CDC) for national reporting.
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provided risk factor information. Of these, 44 percent were homosexual/bisexual
males and 26 percent were IV drug abusers. Seven percent gave a history of both.
(Refer to Table 4.)
Since the patient treatment file (PTF: an automated data-processing system for
storing clinical data on VA patients) has not distinguished AIDS from ARC until the
current fiscal year, no reliable data exist on mean length ofhospital inpatient stay. An
unpublished study of 90 VA cases (the last ten patients discharged from nine VAMCs
in fiscal year 1986) showed, however the average length of stay to be 21.9 days, with
each patient averaging 2.5 admissions in fiscal year 1986. Length of stay data varies
with location. Patients in the four greater New York area hospitals had an average
length of stay of 27.8 days with 2.9 admissions, while the three California hospitals
showed 12.6 days and 3.0 admissions. Seventy percent of the New York cases were IV
drug abusers, while only 20 percent of those in California were.
The VA, early on, established health care policy guidelines in relation to the
management of AIDS patients and patients with the spectrum of illnesses caused by
the HIV (human immunodeficiency virus) [8]. The overriding policy for the Depart-
ment of Medicine and Surgery (DM&S) is to provide quality medical care to all
eligible veterans in a timely and compassionate manner. This policy objective is no
different for patients with AIDS.
The VA established firmly that VA employees were expected to provide care to
veterans with AIDS, and there have been relatively few incidents that reached Central
Office level. The emphasis has been on continuing education of staff and patients and
clear guidance that these patients are veterans who have earned the care through
service to our country.
The VA provides the entire spectrum of health care, including acute and extended
hospital care, nursing home care, hospital-based home care, and domiciliary and
residential care placement. AIDS patients are receiving care in VA nursing homes,
although placement in community nursing homes has been difficult. These are also
patients with AIDS living in VA domiciliaries which provide a relatively independent
living environment with medical supervision on the grounds of VA medical centers.
VA Update
Recently, a decision was made to fund an AIDS unit at the Manhattan VA Medical
Center. A request for proposals (RFP) will be sent to seven additional medical centers
experiencing relatively large AIDS-related workloads. It is expected that two or three
additional units wll be created.
The issues surrounding AIDS are legion. The author, in the course of preparing a
videotape for the VA health care system, identified over twenty different issues, not the
least of which were human T-cell lymphotropic virus type III (HTLV-III) or HIV
screening, risks to health care professionals, psychosocial aspects in the management of
patients with AIDS, confidentiality of records, homophobia, and so on.
In the early years (1982 and 1983), it seemed that relatively few people were taking
this disease seriously. Obviously the direct care givers were! We find the situation
remarkably different today. One statistic which tends to gain immediate attention is
that taken from the report of the Coolfont Planning Conference held in June 1986, in
Berkeley Springs, West Virginia (Public Health Service Plan for the Prevention and
Control ofAIDS and the AIDS Virus), referred to earlier in this article. As stated, the
projected number ofcumulative cases to be diagnosed (given present trends) at the end
of 1991 -the tenth aniversary ofthis disease in the United States-is 270,000. The VA
521H.D. COHN
has regularly seen, basedon theaforementioned VA reporting system, approximately 6
percent of the total number of cases reported by the Centers for Disease Control.
Again, using the same assumptions and current trends, we would project that over
16,000 cases, cumulatively, would be treated in the VA health care system by the end
of 1991. Of course, these figures will be revised downward should major therapeutic
and/or preventive breakthroughs occur.
Costs ofCaringfor AIDS Patients
AIDS patients do not fit well into the diagnosis-related groups (DRG)-driven
reimbursement methodology utilized by the VA. There have been numerous attempts
both in the VA andout toarrive atcostprojections percase. Inordertoberesponsive to
individual facility needs, VA Central Office has attempted to find a more rational way
of funding facilities for AIDS cases. A facility's resources are based on the workload
performed two fiscal years previously. Because AIDS is a comparatively new disease
that is increasing at a rapid rate and is unevenly distributed around the country, it
represents a special challenge for the relatively few VA centers that care for the
majority ofthe agency's AIDS workload. In fiscal year 1985, we estimated that it cost
$38,000 per year to treat an AIDS patient. A more recent study determined that
$24,000 a year is a more appropriate figure. A questionnaire, which was sent to 11
facilities that had a high number ofreported AIDS cases, was devised. The question-
naire asked for certain information concerning the facility's last ten AIDS patients in
fiscal year 1986. Using this data, we estimated that the Resource Allocation Meth-
odology (the diagnosis-related groups [DRG]-driven system) provided funding of
approximately $8,000 per AIDS case to VA medical centers, obviously resulting in a
shortfall.
Based on reduced lengths ofstay, less use ofintensive care unit days, and improved
facilities to manage these patients, it is believed that the cost of an AIDS patient has
decreased about 20 percent since fiscal year 1985. As a result, the VA is using $20,000
as an estimate ofcost per patient per year for fiscal year 1987. Based on this estimate,
supplemental funding was provided for those facilities that cared for more than 15
cases in fiscal year 1987.
Although treatment costs appear to be coming down, the treatment outlook is
unchanged (except for the emergence ofzidovudine, formerly called AZT, for selected
cases). Increased use ofthis drug will tend to offset reduced costs; the drug itselfcosts
from $7-10,000 per year per patient. Also, since the drug is toxic and requires close
monitoring, including various laboratory studies, additional costs will be incurred.
Educational Activities
In fiscal year 1986, the Regional Medical Education Centers (RMECs) conducted
12 continuing education activities, training 1,240 VA participants on the subject of
AIDS. In addition, in fiscal year 1986 the Cooperative Health Manpower Education
Programs (CHEPs) trained 53 VA participants in four continuing education activities.
In fiscal year 1987 to date, the RMECs have trained 440 VA participants in three
continuing education activities.
Examples ofthese activities include:
Care ofthe AIDS patient
AIDS: Nursing concern and management
AIDS overview and VA update
AIDS: Psychosocial aspects
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Results of a RMEC survey on AIDS training conducted at VA medical centers in
fiscal year 1985 revealed that the majority of the training conducted was general
information/orientation/awareness in content and involved staff from all services.
Over 30,000 staffwere trained at 129 VAMCs in fiscal year 1985.
The ten VA medical centers currently with the highest number of AIDS cases
reported patient and family education activities involving a widevariety oftopics. This
information is available to inpatients, outpatients, and veterans in the community
through VA Health Fairs as well as VA staff participation in community activities,
including community nursing homes, volunteers, families and significant others,
recovering drug abuse patients, "worried well" (exposed to virus and/or HIV-
positive), and zidovudine (formerly AZT) protocol participants.
The Office of Academic Affairs in Central Office is establishing a comprehensive
VA-wide AIDS patient and family education program. This assessment will include
program components, target audiences, and print and non-print materials supporting
educational activities and the name of the contact person of each VAMC, and will
provide the information necessary to assist those VAMCs that need help in developing
effective patient health education programs related to the following information:
HIV screening
Confidentiality and privacy ofthe individual infected with AIDS
Cause ofAIDS
Major avenues oftransmission
Methods to prevent spread ofAIDS
Treatment ofAIDS
AIDS support groups
AIDS as a public health issue and its impact on society
Follow-up and availability of outreach program services such as housing, shop-
ping, transportation, cleaning, cooking, finance, job counseling, emotional
support, testing centers for family and significant others, home care, barbers,
legal issues, wills, and so on
"Look-back program" (blood transfusion-related)
Principles ofinfection control; skills in home care for care giver
Clinical drug trial programs
In addition, the Office ofAcademic Affairs (OAA) conducts monthly bibliographic
citation searches on AIDS and distributes this information to RMECs, CHEPs, and
chairpersons of VAMC Public Health Education Committees. A search for audiovi-
suals related to AIDS has been conducted and the audiovisual materials have been
distributed to RMECs.
Current Action Plan
The VA, as have other federal health care agencies, has developed an action plan
with four components:
1. General
a. VA Central Office staff will continue to maintain a reporting system,
including data on risk-group membership. Thegoal is toaugmentthesystem
to include other manifestations of HIV infection.
b. DM&S is committed to working closely with the Department of Defense
(DoD). One issue of paramount importance is the smooth transfer of
patients discharged from the military to VA care.
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c. Supplemental funding was provided in fiscal year 1986 and fiscal year 1987
to those facilities treating more than a minimal number of cases on the
premise that significant caseloads of AIDS patients place unusual burdens
on a medical center in terms of diagnostic and treatment resources,
multidisciplinary staff time, education, and surveillance. The goal is to
develop a formula for resource allocation that would permit funding on a
more timely basis.
d. Seventeen formal communications have been sent from VACO to field
personnel in the Department of Medicine and Surgery. Three others are in
the Central Office concurrence process. There is a clear recognition of the
fact that policy must be set centrally, but that implementation occurs in the
field at the bedside.
e. VA's DM&S will continue to participate in Domestic Policy Council Work
Group meetings and will exchange data with all appropriate individuals.
f. A formal policy for expanded HIV testing is under development.
2. Clinical Care
Assuring the continued state-of-the art management of patients with AIDS and
ARC is ofparamount importance. The VA will:
a. Proceed todevelop AIDS units in selected VA facilities located in epicenters
ofthe disease
b. Enhance laboratory capabilities, particularly in the areas of virology,
immunology, microbiology, and HIV antibody testing
c. Establish psychosocial support groups
d. Cooperate with blood collection agencies and implement and complete
"look-back" programs for transfusion-related AIDS
e. Cooperative with VA's Department of Veterans Benefits in assuring that
disability ratings reflect current medical understanding ofthe disease
3. Education
The need for education of patients with AIDS, ARC, or asymptomatic HIV
infection, their families and/or significant others, and staffs caring for HIV-infected
patients is an ongoing concern. The VA will:
a. Encourage local educational programs using infection control personnel,
infection disease consultants, and appropriate library resources (films,
videotapes, and so forth) for all levels ofemployees
b. Encourage RMECs (there are seven such centers in the VA system) to
develop programs on various aspects ofAIDS
c. Continue to keep the field informed on VA policy and recommendations by
way ofcirculars, information letters, and the like.
4. Research
The spread of the disease and the fatal outcome can ultimately be reversed only
through continuing epidemiologic studies, basic research, clinical investigational trials
ofpromising new drugs, and, ultimately, vaccine development. The Veterans Adminis-
tration will support AIDS research that is particularly relevant to its health care
mission.
a. The VA is currently involved in a multi-center trial ofzidovudine in patients
with ARC.
b. It will continue to support investigator-initiated research.
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c. It will encourage VA investigators to compete for extramural research
funding (DoD, National Institutes of Health [NIH], private foundations,
and so on).
d. It will cooperate with DoD (see 1. b., above).
CONCLUSION
A briefoverview ofthe historical evolution ofAIDS, the epidemiology, and data on
risk-group patterns has been presented. Certain clinical aspects are emphasized.
As with the nation at large, AIDS is having a significant effect on VA Medical
Centers located in the coastal regions of the United States. The VA's overall
experience, including morbidity and mortality data and definition of the groups at
greatest risk, generally reflects that seen in the non-federal health care sector.
AIDS and AIDS-rela,ted diseases are grave illnesses, requiring all manner of
commitment to high-quality clinical care, patient sensitivity, interagency collabora-
tion, and innovative educational, research, and administrative activities.
The VA, as the nation's largest centrally directed public health care system, will
continue to be responsive to these requirements.
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